Mesenchymal Stromal Cell Phenotype is not Influenced by Confluence during Culture Expansion
- 30 May 2012
- journal article
- Published by Springer Science and Business Media LLC in Stem Cell Reviews and Reports
- Vol. 9 (1), 44-58
- https://doi.org/10.1007/s12015-012-9386-3
Abstract
Accumulating preclinical and clinical evidence indicates that human mesenchymal stromal cells (MSCs) are good candidates for cell therapy. For clinical applications of MSCs extensive in vitro expansion is required to obtain an adequate number of cells. It is evident that the pursuit for cell quantity must not affect quality, but it is also a fact that in vitro culture conditions affect MSC phenotype. One possible variable is the degree of cell confluence during expansion. We investigate the influence of cell density on homogeneity and differentiation during culture expansion of un-stimulated MSCs isolated from the bone marrow in DMEM and fetal bovine serum (FBS). MSC morphology, phenotype and differentiation were investigated weekly during 5 weeks culture expansion using electron microscopy, flow cytometry, immunocytochemistry, qualitative RT-PCR and quantitative Q-PCR. The morphological observation and the phenotypic analyses showed that MSCs after 3 weeks cultivation constituted a phenotypically homogenous MSC cell population, which at low levels expressed genes for different cell lineages, confirming their multilineage plasticity, without actual differentiation. This phenotype persisted independent of increasing cell densities. These data demonstrate that MSC characteristics and plasticity can be maintained during culture expansion from bone marrow mononuclear cells to MSCs and that a homogeneous phenotype of undifferentiated MSCs which persists independent of cell density can be used for clinical therapies.Keywords
This publication has 75 references indexed in Scilit:
- Direct Intramyocardial Mesenchymal Stromal Cell Injections in Patients with Severe Refractory Angina: One-Year Follow-UpCell Transplantation, 2013
- Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?EPMA Journal, 2011
- Serum Free Cultured Bone Marrow Mesenchymal Stem Cells as a Platform to Characterize the Effects of Specific MoleculesPLOS ONE, 2010
- Effects of plating density and culture time on bone marrow stromal cell characteristicsExperimental Hematology, 2008
- Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized ProcessPLOS ONE, 2008
- Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseasesCell and tissue research, 2007
- Ex vivo generation of mature and functional human smooth muscle cells differentiated from skeletal myoblastsExperimental Cell Research, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite of extensive proliferationBiochemical and Biophysical Research Communications, 2005
- Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarctionThe American Journal of Cardiology, 2004